Stock Price Quote

KABRA DRUGS LTD.

NSE : NABSE : 524322ISIN CODE : INE323K01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE7.190 (0 %)
PREV CLOSE ( ) 7.19
OPEN PRICE ( ) 7.19
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2457
TODAY'S LOW / HIGH ( )7.19 7.19
52 WK LOW / HIGH ( ) 3.187.19
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989
Management Info
- Chairman - Managing Director
Registered Office

Address Shop No 270,Shastri Market, ,
Indore,
Madhya Pradesh-452001

Phone 0731- 4247626

Email kabradrugs@gmail.com

Website www.kabradrugs.com

Registrars Details
Skyline Financial Services Pvt Ltd
A/505, Dattani Plaza, Andheri Kurla Road,Safeed Pool,Andheri East,Mumbai
Listing : BSE, Indore

NEWS

06Mar Kabra Drugs informs about revised unau
Kabra Drugs has informed that it enclosed Revised Unaudited Result for t..
19Feb Kabra Drugs informs about voting resul
Pursuant to Regulation 30 and 44(3) of the SEBI (Listing Obligations and..
16Feb Kabra Drugs submits statement of inves
Pursuant to Regulation 13(3) of SEBI (LODR) Regulation 2015, Kabra Drugs..
23Jan Allotment of Equity Shares
Inter alia to consider and approve the following matters: To consider a..
18Jan Allotment of Equity Shares
Preferential Issue of shares & Increase in Authorised Capital Inter ali..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-1.09-3.39
Gross Profit -1.09 -3.39
Operating Profit -1.09-3.39
Net Sales 0.06

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
peergroup  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
peergroup  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
peergroup  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
peergroup  1943.10 (3.26%)
M.Cap ( in Cr)32917.29

Shareholding Pattern

NON-INSTITUTION 100%
PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Kabra Drugs Ltd.

Kabra Drugs Ltd. was incorporated in the year 1989. Its today's share price is 7.19. Its current market capitalisation stands at Rs 3.16 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0.06 Cr. The company's management includes BV Anatha Kumar, Monika Nishant Lal Sanwal, A Anitha, Kuniamuthur Nanjappan Anand, Ananthkumar Shilpa.

It is listed on the BSE with a BSE Code of 524322 , NSE with an NSE Symbol of and ISIN of INE323K01017. It's Registered office is at Shop No 270,Shastri Market, Indore-452001, Madhya Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Agrawal Jhavar Associates, Agrawal Jhawar & Associates, Ashok Khasgiwala & Co, Rishi Sekhri & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.